Focusing on the development and industrialization of nucleic acid medicines
Focusing on the development and industrialization of nucleic acid medicines
Possesses a proprietary RNA-based Therapeutic Platform (RTP) independently developed for nucleic acid medicines

Partners

RongCan Biotech has established a joint research center cooperating with the School of Pharmacy at Shanghai Jiao Tong University, and now is developing mRNA-based COVID-19 (variant strain) vaccines in cooperation with well-known domestic companies.
111
111
222
Contact Us
Telephone : 021-3508 1701
E-mail : rcsw@rc-rna.com
Address : Room 306, 3rd Floor, Building 3, No.248 Guanghua Road, Minhang District, Shanghai
Copyright © 2020-2021 RongCan（Shanghai）Biotech Co., Ltd  沪ICP备2021034162号